|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.200 HKD | +3.90% |
|
-1.23% | -29.52% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 1,003 | - | - |
| Change | - | -30.05% | -30.06% | -32.35% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 1,072 | 1,003 | 841.2 |
| Change | - | -16.83% | -28.53% | -27.03% | -6.41% | -16.12% |
| P/E | -1.04x | -4.72x | -3.96x | -6.02x | 21.2x | 2.66x |
| PBR | 2.25x | 2.17x | 1.52x | 2.18x | 1.98x | 1.43x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 1.55x | 0.85x | 0.58x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.66x | 0.85x | 0.48x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -9.02x | 12.3x | 1.89x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -7.48x | 19x | 3.45x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -3.49x | -35.5x | 13.6x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -28.6% | -2.82% | 7.33% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 2.760 | 2.760 | 2.760 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 3/27/24 | 3/24/25 | 3/24/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.8x | 1.6x | -8.7x | - | 143M | |
| 32.54x | 11.83x | 24.36x | 0.61% | 992B | |
| 25.03x | 5.77x | 15.69x | 2.28% | 564B | |
| 27.45x | 6.62x | 13.53x | 3.1% | 391B | |
| 17.47x | 4.34x | 10.68x | 3.06% | 330B | |
| 22.62x | 4.72x | 13.39x | 1.85% | 280B | |
| 21.12x | 5.46x | 13.25x | 2.94% | 279B | |
| 12.67x | 4.72x | 9.72x | 3.98% | 196B | |
| 22.21x | 5.97x | 10.43x | 2.95% | 184B | |
| -44.95x | 5.42x | 29.92x | 2.59% | 156B | |
| Average | 13.04x | 5.65x | 13.23x | 2.59% | 337.14B | |
| Weighted average by Cap. | 22.15x | 7.33x | 17.13x | 2.13% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
